Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 3c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.47), $0.03 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Duerr AG (DUE:GR) (DURYY) PT Lowered to EUR21 at Deutsche Bank
• Burry says he is short Micron